[Form 4] Vital Farms, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Vital Farms, Inc. (VITL) Form 4: Director Karl Khoury reported the sale of 20,000 shares of Vital Farms common stock on 08/13/2025 at a weighted average price of $47.63 per share, with prices in the range $47.60 to $47.64. After the sale, Mr. Khoury beneficially owned 114,789 shares. The Form 4 was signed by an attorney-in-fact on 08/15/2025 and indicates the filing was submitted by a single reporting person. The filing discloses the weighted-average pricing and offers to provide details of the number of shares sold at each price within the stated range.

Insights

Securities Analyst

TL;DR: Insider sale of 20,000 shares by a director is disclosed; transaction appears routine and fully reported.

The filing documents a single open-market sale by Director Karl Khoury on 08/13/2025 for a weighted average price of $47.63 per share. The report provides the realized price range and the residual beneficial ownership of 114,789 shares, which helps investors track insider liquidity and alignment. As reported, the transaction is granular (multiple prices within a narrow band) and the filer commits to provide breakdowns if requested, supporting transparency. No derivative transactions or additional material changes are disclosed.

Corporate Governance Expert

TL;DR: Disclosure is compliant and specific; the sale reduces an individual director's stake but presents no governance event.

The Form 4 shows compliance with Section 16 reporting requirements by providing transaction date, sale amount, weighted-average pricing, and post-transaction holdings. The report was executed by an attorney-in-fact and filed by one reporting person. While the director reduced holdings by 20,000 shares, the filing contains no information about any change in board membership, related-party arrangements, or unusual timing that would indicate a governance concern. The disclosure meets basic transparency standards.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Khoury Karl

(Last) (First) (Middle)

C/O VITAL FARMS, INC.

3601 SOUTH CONGRESS AVENUE, SUITE C100

(Street)

AUSTIN TX 78704

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vital Farms, Inc. [ VITL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2025		S		20,000	D	$47.63(1)	114,789	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.60 to $47.64 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Francis Cullo, Attorney-in-Fact	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Karl Khoury report in the Form 4 for VITL?

The Form 4 reports a sale of 20,000 Vital Farms shares on 08/13/2025 at a weighted average price of $47.63 per share and post-sale beneficial ownership of 114,789 shares.

At what prices were the VITL shares sold by the director?

The filing states the shares were sold in multiple transactions at prices ranging from $47.60 to $47.64, with a weighted average of $47.63.

When was the Form 4 for the VITL transaction signed and filed?

The Form 4 bears a signature by an attorney-in-fact dated 08/15/2025 and reports the earliest transaction date as 08/13/2025.

Does the Form 4 show any derivative transactions for VITL by Karl Khoury?

No. Table II (derivative securities) contains no reported transactions; only a non-derivative sale of common stock is reported.

Was this Form 4 filed by multiple reporting persons?

No. The form indicates it was filed by one reporting person.